Published: November 10, 2025
Key takeaways today
- Nvidia (NVDA) management says demand for Blackwell AI chips is “very strong” as the company pushes TSMC for more wafers; CEO Jensen Huang reiterated there are no active discussions to sell Blackwell into China. Reuters+1
- Pfizer (PFE) tightened its grip on the anti‑obesity race: Metsera’s board reaffirmed support for the amended Pfizer–Metsera deal ahead of a Nov. 13 vote, after a weekend of take‑over drama.
- Nio (NIO) said it’s “still confident” about turning profitable in Q4—even as China’s October car sales surprised to the downside—keeping sentiment headline‑sensitive. EV – EVerything around EVs+1
- Joby Aviation (JOBY) joined a consortium selected by the Tokyo Metropolitan Government for Phase I of its eVTOL implementation plan—another commercialization step for 2026+ launches.
- Alphabet (GOOGL) remains a high‑beta beneficiary of AI and holiday ad demand; tech led a broad pre‑market rebound today, with momentum still underpinned by Alphabet’s record $100B+ quarter late last month.
Why these five?
Today’s market is rewarding near‑term, verifiable catalysts—product cycles (NVDA), M&A (PFE), monthly prints and policy (NIO), certification milestones (JOBY), and AI‑plus‑ads seasonality (GOOGL). That mix aligns with the “fast‑profit” focus highlighted by Traders Union’s latest screen, which zeroes in on GOOGL, NVDA, PFE, NIO and JOBY as names where news flow drives outsized moves. Traders Union
Nvidia (NVDA): Blackwell demand, wafer asks, and China stance
What changed today: Over the weekend in Taiwan, CEO Jensen Huang said demand for Nvidia’s Blackwell platform remains “very strong,” adding that the company is asking TSMC for more wafers to keep pace. He also repeated there are no active discussions about selling Blackwell into China, reinforcing the U.S.–China export overhang that traders are watching into year‑end. Reuters+1
Why it matters for fast trades:
- Supply visibility (wafer commitments) supports top‑line confidence into the next product ramps.
- Policy clarity tempers one source of headline risk (scaled‑down China hopes) but keeps positioning tight around any export‑rule headlines.
Next catalysts: Follow‑through commentary from TSMC and any U.S./China export updates that alter expected Blackwell allocations.
Pfizer (PFE): Metsera deal momentum into Thursday’s vote
What changed today: Metsera’s board reaffirmed support for Pfizer’s amended merger agreement (cash plus CVR up to $86.25 per share) ahead of the Nov. 13 special meeting, after Novo Nordisk stepped back. That follows Reuters’ weekend confirmation that Pfizer clinched the ~$10B bidding war.
Why it matters for fast trades:
- Deal clarity reduces event risk and strengthens Pfizer’s late‑cycle obesity strategy—an area investors view as critical to medium‑term growth.
- Timeline specificity (shareholder vote this week) creates a clear news window for momentum‑driven moves.
Watch next: Final vote results (Nov. 13) and any FTC commentary given the antitrust sensitivities flagged in recent communications.
Nio (NIO): Profitability push vs. softer China auto backdrop
What changed today: In a Q&A with customers, founder/CEO William Li said Nio is “still confident” it can reach Q4 profitability, calling it a “quite big” challenge while emphasizing cost control and delivery execution. Meanwhile, China passenger‑car sales unexpectedly contracted in October, signaling a tougher retail backdrop even as EV adoption remains elevated. EV – EVerything around EVs+1
Why it matters for fast trades:
- Management tone supports bull‑case narratives on margin traction.
- Macro friction (China retail softness, subsidy fade) can swing sentiment quickly—perfect for catalyst‑driven setups around monthly delivery prints.
Context: Nio posted a record 40,397 October deliveries (up 92.6% YoY), giving it operational room to chase Q4 targets as production scales.
Joby Aviation (JOBY): Tokyo selects consortium with Joby aircraft
What changed today: The Tokyo Metropolitan Government selected a multi‑company consortium (Nomura Real Estate lead) for Phase I of its “eVTOL Implementation Project,” explicitly featuring Joby and SkyDrive aircraft for multi‑use case planning and vertiport siting—another step toward Asian market adoption. Business Wire
Why it matters for fast trades:
- Policy‑backed projects de‑risk the commercialization path and often spark speculative flows across the eVTOL cohort.
- The milestone lands days after Joby entered the final stage of FAA type certification with power‑on testing of its first conforming aircraft—keeping U.S. and international timelines in focus.
What to watch: Follow‑ups from Tokyo’s program (site selection timelines) and any FAA updates that pull forward first‑flight windows.
Alphabet (GOOGL): AI + holiday tailwinds, tech leads today’s bounce
What changed today: U.S. futures rebounded, led by big‑cap tech and AI names; Alphabet participated in the bounce as risk appetite improved around Washington progress on the shutdown.
Why it matters for fast trades:
- Alphabet’s late‑October earnings delivered the company’s first‑ever $100B+ quarter, with higher capex aimed at monetizing AI in Search, YouTube and Cloud—keeping the stock sensitive to broader AI momentum days like today.
- Into the holidays, ad‑spend narratives remain constructive and can fuel short‑term follow‑through on green tech sessions.
Fast‑profit playbook for today
- Lean into scheduled catalysts: Pfizer’s Nov. 13 vote; track Tokyo’s eVTOL follow‑ups and any FAA bulletins for Joby.
- Respect policy tape bombs: Nvidia’s China stance helps, but export headlines can still jar AI hardware names intraday.
- Price the macro in China EVs: Nio’s profitability path competes with softer China retail data—manage risk around delivery updates and policy chatter.
Sources & further reading
- Traders Union: “Best stocks for fast profit: GOOGL, NVDA, PFE, NIO, JOBY.” (Nov. 10, 2025). Traders Union
- Nvidia/TSMC/China: Reuters—Huang sees strong Blackwell demand; “no active discussions” on China sales. (Nov. 8–7, 2025). Reuters+1
- Pfizer–Metsera: BioSpace press release—Metsera board reaffirms support for amended Pfizer deal (Nov. 10, 2025); Reuters wrap on bidding war (updated Nov. 10, 2025).
- Nio & China autos: EV news Q&A (Nov. 10, 2025) and Reuters—China car sales slipped in October (Nov. 10, 2025). Plus Nio’s Oct. delivery record via GlobeNewswire (Nov. 1, 2025).
- Joby Aviation/Tokyo: Business Wire—Tokyo selects consortium featuring Joby & SkyDrive (Nov. 10, 2025).
- Alphabet: U.S. futures/tech rebound (Reuters, Nov. 10, 2025) and Alphabet Q3 beat/capex update (Reuters, Oct. 29–30, 2025).
Editorial note: This article is for information only and not investment advice. Always do your own research and consider your risk tolerance before trading.
